Literature DB >> 11145896

1-Methylguanosine in place of Y base at position 37 in phenylalanine tRNA is responsible for its shiftiness in retroviral ribosomal frameshifting.

B A Carlson1, J F Mushinski, D W Henderson, S Y Kwon, P F Crain, B J Lee, D L Hatfield.   

Abstract

Many mammalian retroviruses express their protease and polymerase by ribosomal frameshifting. It was originally proposed that a specialized shifty tRNA promotes the frameshift event. We previously observed that phenylalanine tRNA(Phe) lacking the highly modified wybutoxosine (Y) base on the 3' side of its anticodon stimulated frameshifting, demonstrating that this tRNA is shifty. We now report the shifty tRNA(Phe) contains 1-methylguanosine (m(1)G) in place of Y and that the m(1)G form from rabbit reticulocytes stimulates frameshifting more efficiently than its m(1)G-containing counterpart from mouse neuroblastoma cells. The latter tRNA contains unmodified C and G nucleosides at positions 32 and 34, respectively, while the former tRNA contains the analogous 2'-O-methylated nucleosides at these positions. The data suggest that not only does the loss of a highly modified base from the 3' side of the anticodon render tRNA(Phe) shifty, but the modification status of the entire anticodon loop contributes to the degree of shiftiness. Possible biological consequences of these findings are discussed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145896     DOI: 10.1006/viro.2000.0692

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Transfer RNA modifications that alter +1 frameshifting in general fail to affect -1 frameshifting.

Authors:  Jaunius Urbonavicius; Guillaume Stahl; Jérôme M B Durand; Samia N Ben Salem; Qiang Qian; Philip J Farabaugh; Glenn R Björk
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

Review 2.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

Review 3.  A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment.

Authors:  John F Atkins; Glenn R Björk
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

Review 4.  tRNA's modifications bring order to gene expression.

Authors:  Estella M Gustilo; Franck Ap Vendeix; Paul F Agris
Journal:  Curr Opin Microbiol       Date:  2008-04-02       Impact factor: 7.934

Review 5.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

Review 6.  Transfer RNA methytransferases and their corresponding modifications in budding yeast and humans: activities, predications, and potential roles in human health.

Authors:  William L Towns; Thomas J Begley
Journal:  DNA Cell Biol       Date:  2011-12-22       Impact factor: 3.311

7.  Influence of the stacking potential of the base 3' of tandem shift codons on -1 ribosomal frameshifting used for gene expression.

Authors:  Claire Bertrand; Marie Françoise Prère; Raymond F Gesteland; John F Atkins; Olivier Fayet
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

8.  The role of wobble uridine modifications in +1 translational frameshifting in eukaryotes.

Authors:  Hasan Tükenmez; Hao Xu; Anders Esberg; Anders S Byström
Journal:  Nucleic Acids Res       Date:  2015-08-17       Impact factor: 16.971

9.  Ribosomal frameshifting in response to hypomodified tRNAs in Xenopus oocytes.

Authors:  Bradley A Carlson; Byeong Jae Lee; Dolph L Hatfield
Journal:  Biochem Biophys Res Commun       Date:  2008-08-12       Impact factor: 3.575

Review 10.  Decoding the genome: a modified view.

Authors:  Paul F Agris
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.